 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
December 12, 2012
Sequencing Studies Lead to New Clinical Trial for Overlooked HER2 Mutations in Breast Cancer
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Wash U Team Aims to Develop Sequencing-Based Individualized Vaccines for Breast Cancers
April 26, 2011 / Clinical Sequencing News - Wash U Awarded $6.5M Grant to Develop Sequencing-Based Breast Cancer Vaccine
April 19, 2011 / Clinical Sequencing News - Wash U Team Looks to Expand on Initial Success of Sequencing in Breast Cancer Clinical Trial
April 5, 2011 / Clinical Sequencing News - At AACR, Early Providers of NGS-based Cancer Panels Debate 'Actionable' Mutations, Regulatory Issues
April 10, 2013 / Clinical Sequencing News - Sequencing, Though Not Always a Slam Dunk, Gains Traction in Genomic Medicine
March 13, 2013 / Clinical Sequencing News